Señales en vivo de TMO | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide...

Stats
Volumen de hoy	1.75M
Volumen promedio	1.34M
Capitalización de mercado	218.49B
EPS	$0 ( 2024-04-24 )
Próxima fecha de ganancias	( $5.13 ) 2024-07-24
Last Dividend	$0.350 ( 2023-12-14 )
Next Dividend	$0 ( N/A )
P/E	36.76
ATR14	$0.280 (0.05%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Casper Marc N	Buy	10 000	Common Stock
2024-05-01	Casper Marc N	Sell	378	Common Stock
2024-05-01	Casper Marc N	Sell	1 400	Common Stock
2024-05-01	Casper Marc N	Sell	2 100	Common Stock
2024-05-01	Casper Marc N	Sell	1 145	Common Stock

INSIDER POWER
-62.75
Last 98 transactions
Buy: 76 634 \| Sell: 328 022

Volumen Correlación

Largo: -0.65 (weak negative)

Corto: -0.25 (neutral)

Signal:(30.039) Neutral

Thermo Fisher Scientific Correlación

10 Correlaciones Más Positivas
GOEX	0.806
NUGT	0.806
GDXJ	0.805
SGDJ	0.801

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Thermo Fisher Scientific Correlación - Moneda/Commodity

0.64
( weak )

0.29
( neutral )

0.49
( neutral )

0.51
( weak )

-0.17
( neutral )

-0.04
( neutral )

Thermo Fisher Scientific Finanzas

Annual	2023
Ingresos:	$42.86B
Beneficio Bruto:	$15.22B (35.52 %)
EPS:	$15.53

FY	2023
Ingresos:	$42.86B
Beneficio Bruto:	$15.22B (35.52 %)
EPS:	$15.53

FY	2022
Ingresos:	$44.92B
Beneficio Bruto:	$19.50B (43.42 %)
EPS:	$17.73

FY	2021
Ingresos:	$39.21B
Beneficio Bruto:	$19.64B (50.08 %)
EPS:	$19.62

Financial Reports:

No articles found.

Thermo Fisher Scientific Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.300 (N/A)	$0.300 (N/A)	$0.350 (N/A)	$0.350 (N/A)	$0.350 (N/A)	$0.350 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Thermo Fisher Scientific Dividend Information - Dividend Knight

Dividend Sustainability Score: 9.13 - good (91.31%) | Divividend Growth Potential Score: 6.05 - Stable (20.96%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0430	1993-08-06
Last Dividend	$0.350	2023-12-14
Next Dividend	$0	N/A
Payout Date	2024-01-16
Next Payout Date	N/A
# dividends	52	--
Total Paid Out	$12.89	--
Avg. Dividend % Per Year	0.15%	--
Score	4.36	--
Div. Sustainability Score	9.13
Div.Growth Potential Score	6.05
Div. Directional Score	7.59	--

Next Divdend (Est)
(2024-07-05)

$0.358 Estimate 34.05 %

Dividend Stability

0.68 Above Average

Dividend Score

4.36

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1993	$0.0430	0.31%
1994	$0	0.00%
1995	$0	0.00%
1996	$0.00400	0.01%
1997	$0	0.00%
1998	$0	0.00%
1999	$0	0.00%
2000	$0	0.00%
2001	$3.34	11.50%
2002	$0	0.00%
2003	$0	0.00%
2004	$0	0.00%
2005	$0	0.00%
2006	$0	0.00%
2007	$0	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0.540	1.15%
2013	$0.600	0.92%
2014	$0.600	0.55%
2015	$0.600	0.47%
2016	$0.600	0.43%
2017	$0.600	0.42%
2018	$0.680	0.35%
2019	$0.760	0.35%
2020	$0.880	0.27%
2021	$1.040	0.22%
2022	$1.200	0.19%
2023	$1.400	0.25%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
ZTR	Dividend King	2024-02-09	Monthly	37	8.35%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.142	1.500	7.16	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0621	1.200	7.93	9.51	[0 - 0.3]
returnOnEquityTTM	0.133	1.500	9.63	10.00	[0.1 - 1]
payoutRatioTTM	0.0897	-1.000	9.10	-9.10	[0 - 1]
currentRatioTTM	1.696	0.800	6.52	5.22	[1 - 3]
quickRatioTTM	1.192	0.800	7.70	6.16	[0.8 - 2.5]
cashRatioTTM	0.395	1.500	8.92	10.00	[0.2 - 2]
debtRatioTTM	0.367	-1.500	3.89	-5.83	[0 - 0.6]
interestCoverageTTM	-103.18	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	23.37	2.00	2.21	4.42	[0 - 30]
freeCashFlowPerShareTTM	19.79	2.00	0.105	0.209	[0 - 20]
debtEquityRatioTTM	0.782	-1.500	6.87	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.412	1.000	6.47	6.47	[0.2 - 0.8]
operatingProfitMarginTTM	0.165	1.000	8.70	8.70	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.251	1.000	9.72	9.72	[0.2 - 2]
assetTurnoverTTM	0.438	0.800	-0.416	-0.333	[0.5 - 2]
Total Score				9.13

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	36.24	1.000	6.44	0	[1 - 100]
returnOnEquityTTM	0.133	2.50	9.76	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	19.79	2.00	3.40	0.209	[0 - 30]
dividendYielPercentageTTM	0.252	1.500	3.71	0	[0 - 0.4]
operatingCashFlowPerShareTTM	23.37	2.00	2.21	4.42	[0 - 30]
payoutRatioTTM	0.0897	1.500	9.10	-9.10	[0 - 1]
pegRatioTTM	11.24	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.210	1.000	7.25	0	[0.1 - 0.5]
Total Score				6.05

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.